Sandra Koch

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

Association of killer cell immunoglobulin‐like receptors with scleroderma

Tanja Momot, Sandra Koch, Nicolas Hunzelmann et al. · Arthritis & Rheumatism · 2004 · 139 citations

Life Sciences, Genetics, Immunology +17

Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort

Bernhard Scheiner, Martha M. Kirstein, Florian Hucke et al. · Alimentary Pharmacology & Therapeutics · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

Sandra Koch, Frank Mayer, Friedemann Honecker et al. · British Journal of Cancer · 2003 · 123 citations · Full text

Medicine, Oncology, Pharmacology +16

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

Arndt Weinmann, Y Alt, Sandra Koch et al. · BMC Cancer · 2015 · 111 citations · Full text

Medicine, Internal Medicine, Oncology +12